Global Polyclonal Antibodies Market Size & Outlook
Global polyclonal antibodies market, 2018-2030 (US$M)
Related Markets
Global polyclonal antibodies market highlights
- The global polyclonal antibodies market generated a revenue of USD 1,566.8 million in 2023 and is expected to reach USD 2,206.4 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 5% by 2030.
- In terms of segment, rabbits accounted for a revenue of USD 791.6 million in 2023.
- Mouse is the most lucrative source segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Germany is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 1,566.8 million |
| Market revenue in 2030 | USD 2,206.4 million |
| Growth rate | 5% (CAGR from 2023 to 2030) |
| Largest segment | Rabbits |
| Fastest growing segment | Mouse |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Rabbits, Goats, Sheep, Mouse |
Other key industry trends
- In terms of revenue, the North America accounted for 38.6% of the global polyclonal antibodies market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Germany is the fastest growing regional market and is projected to reach USD 117.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Polyclonal Antibodies Market Scope
Polyclonal Antibodies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global polyclonal antibodies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polyclonal antibodies market will help companies and investors design strategic landscapes.
Rabbits was the largest segment with a revenue share of 50.52% in 2023. Horizon Databook has segmented the Global polyclonal antibodies market based on rabbits, goats, sheep, mouse covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Polyclonal Antibodies Source Outlook (Revenue, USD Million, 2018-2030)
- Human
- End Use
- Specialty Centers
- Hospitals
- Academic And Research Centers
- Pharmaceutical And Biotechnology Companies
- Diagnostic Centers
- End Use
- Humanized
- End Use
- Specialty Centers
- Hospitals
- Academic And Research Centers
- Pharmaceutical And Biotechnology Companies
- Diagnostic Centers
- End Use
- Chimeric
- End Use
- Specialty Centers
- Hospitals
- Academic And Research Centers
- Pharmaceutical And Biotechnology Companies
- Diagnostic Centers
- End Use
- Murine
- End use
- Specialty Centers
- Hospitals
- Academic And Research Centers
- Pharmaceutical And Biotechnology Companies
- Diagnostic Centers
- End use
- Rabbits
- End Use
- Specialty Centers
- Hospitals
- Academic And Research Centers
- Pharmaceutical And Biotechnology Companies
- Diagnostic Centers
- End Use
- Goats
- End Use
- Specialty Centers
- Hospitals
- Academic And Research Centers
- Pharmaceutical And Biotechnology Companies
- Diagnostic Centers
- End Use
- Sheep
- End Use
- Specialty Centers
- Hospitals
- Academic And Research Centers
- Pharmaceutical And Biotechnology Companies
- Diagnostic Centers
- End Use
- Mouse
- End Use
- Specialty Centers
- Hospitals
- Academic And Research Centers
- Pharmaceutical And Biotechnology Companies
- Diagnostic Centers
- End Use
- Others
- End Use
- Specialty Centers
- Hospitals
- Academic And Research Centers
- Pharmaceutical And Biotechnology Companies
- Diagnostic Centers
- End Use
- Human
Reasons to subscribe to Global polyclonal antibodies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global polyclonal antibodies market databook
-
Our clientele includes a mix of polyclonal antibodies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global polyclonal antibodies market , including forecasts for subscribers. This global databook contains high-level insights into Global polyclonal antibodies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global polyclonal antibodies market size, by region, 2018-2030 (US$M)
Top 10 countries: Polyclonal antibodies market size, 2023 (US$M)
Global polyclonal antibodies market share, by source, 2023 & 2030 (%, US$M)
Polyclonal antibodies market: Opportunity assessment by country
Global polyclonal antibodies market, by region, 2023 (US$M)
| Source | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Latin America | 50.7 | 53.4 | 68.9 | 86.9 | 92.7 | 98.6 | 104.7 | 110.7 | 116.8 | 122.7 | 128.3 | 133.6 | 138.1 | 3.7% |
| Europe | 235.9 | 247.6 | 318.7 | 400.5 | 425.4 | 450.1 | 471.5 | 492.2 | 511.1 | 527.9 | 542.6 | 553.7 | 561.6 | 2.6% |
| North America | 317.7 | 333.1 | 428.3 | 538.0 | 571.4 | 605.5 | 636.8 | 665.8 | 691.9 | 712.7 | 730.3 | 744.8 | 753.9 | 2.6% |
| MEA | 32.4 | 34.0 | 43.8 | 55.2 | 58.6 | 62.2 | 65.8 | 68.8 | 72.0 | 75.1 | 78.3 | 81.4 | 84.3 | 3.3% |
| Asia Pacific | 194.0 | 199.8 | 253.0 | 314.6 | 331.3 | 350.4 | 378.5 | 412.1 | 451.4 | 498.7 | 550.4 | 607.0 | 668.5 | 6.8% |
| Overall | 830.7 | 867.9 | 1,112.7 | 1,395.2 | 1,479.3 | 1,566.8 | 1,657.3 | 1,749.7 | 1,843.3 | 1,937.1 | 2,030.0 | 2,120.6 | 2,206.4 | 5.0% |
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
